nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Metoprolol—CYP2C19—epilepsy syndrome	0.00131	0.126	CrCbGaD
Metipranolol—Dermatitis—Rufinamide—epilepsy syndrome	0.00123	0.00172	CcSEcCtD
Metipranolol—Bronchitis—Gabapentin—epilepsy syndrome	0.00123	0.00171	CcSEcCtD
Metipranolol—Discomfort—Oxcarbazepine—epilepsy syndrome	0.00122	0.00171	CcSEcCtD
Metipranolol—Acute coronary syndrome—Pregabalin—epilepsy syndrome	0.00122	0.00171	CcSEcCtD
Metipranolol—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.00122	0.00171	CcSEcCtD
Metipranolol—Headache—Rufinamide—epilepsy syndrome	0.00122	0.00171	CcSEcCtD
Metipranolol—Somnolence—Fosphenytoin—epilepsy syndrome	0.00122	0.0017	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.00122	0.0017	CcSEcCtD
Metipranolol—Myocardial infarction—Pregabalin—epilepsy syndrome	0.00122	0.0017	CcSEcCtD
Metipranolol—Dizziness—Lacosamide—epilepsy syndrome	0.00121	0.00169	CcSEcCtD
Metipranolol—Conjunctivitis—Pregabalin—epilepsy syndrome	0.00121	0.00168	CcSEcCtD
Metipranolol—Hypertension—Carbamazepine—epilepsy syndrome	0.0012	0.00168	CcSEcCtD
Metipranolol—Oedema—Clonazepam—epilepsy syndrome	0.0012	0.00168	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.0012	0.00168	CcSEcCtD
Metipranolol—Palpitations—Lamotrigine—epilepsy syndrome	0.00119	0.00167	CcSEcCtD
Metipranolol—Myalgia—Carbamazepine—epilepsy syndrome	0.00119	0.00166	CcSEcCtD
Metipranolol—Somnolence—Vigabatrin—epilepsy syndrome	0.00119	0.00166	CcSEcCtD
Metipranolol—Visual impairment—Valproic Acid—epilepsy syndrome	0.00119	0.00166	CcSEcCtD
Metipranolol—Anxiety—Carbamazepine—epilepsy syndrome	0.00118	0.00165	CcSEcCtD
Metipranolol—Nausea—Phenobarbital—epilepsy syndrome	0.00118	0.00165	CcSEcCtD
Metipranolol—Cough—Lamotrigine—epilepsy syndrome	0.00118	0.00164	CcSEcCtD
Metipranolol—Dizziness—Clobazam—epilepsy syndrome	0.00117	0.00164	CcSEcCtD
Metipranolol—Dyspnoea—Diazepam—epilepsy syndrome	0.00117	0.00164	CcSEcCtD
Metipranolol—Somnolence—Diazepam—epilepsy syndrome	0.00117	0.00163	CcSEcCtD
Metipranolol—Epistaxis—Pregabalin—epilepsy syndrome	0.00117	0.00163	CcSEcCtD
Metipranolol—Hypertension—Lamotrigine—epilepsy syndrome	0.00116	0.00163	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.00116	0.00162	CcSEcCtD
Metipranolol—Nausea—Rufinamide—epilepsy syndrome	0.00116	0.00162	CcSEcCtD
Metipranolol—Rash—Lacosamide—epilepsy syndrome	0.00115	0.00161	CcSEcCtD
Metipranolol—Dermatitis—Lacosamide—epilepsy syndrome	0.00115	0.00161	CcSEcCtD
Metipranolol—Acebutolol—CYP2D6—epilepsy syndrome	0.00115	0.11	CrCbGaD
Metipranolol—Myalgia—Lamotrigine—epilepsy syndrome	0.00115	0.0016	CcSEcCtD
Metipranolol—Headache—Lacosamide—epilepsy syndrome	0.00115	0.0016	CcSEcCtD
Metipranolol—Anxiety—Lamotrigine—epilepsy syndrome	0.00114	0.0016	CcSEcCtD
Metipranolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.00114	0.11	CrCbGaD
Metipranolol—Oedema—Carbamazepine—epilepsy syndrome	0.00114	0.00159	CcSEcCtD
Metipranolol—Asthenia—Acetazolamide—epilepsy syndrome	0.00114	0.00159	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.00114	0.00159	CcSEcCtD
Metipranolol—Dyspnoea—Felbamate—epilepsy syndrome	0.00114	0.00159	CcSEcCtD
Metipranolol—Discomfort—Lamotrigine—epilepsy syndrome	0.00113	0.00159	CcSEcCtD
Metipranolol—Bradycardia—Pregabalin—epilepsy syndrome	0.00113	0.00158	CcSEcCtD
Metipranolol—Somnolence—Felbamate—epilepsy syndrome	0.00113	0.00158	CcSEcCtD
Metipranolol—Acute coronary syndrome—Gabapentin—epilepsy syndrome	0.00112	0.00157	CcSEcCtD
Metipranolol—Rash—Clobazam—epilepsy syndrome	0.00112	0.00156	CcSEcCtD
Metipranolol—Dermatitis—Clobazam—epilepsy syndrome	0.00112	0.00156	CcSEcCtD
Metipranolol—Rhinitis—Pregabalin—epilepsy syndrome	0.00112	0.00156	CcSEcCtD
Metipranolol—Myocardial infarction—Gabapentin—epilepsy syndrome	0.00111	0.00156	CcSEcCtD
Metipranolol—Headache—Clobazam—epilepsy syndrome	0.00111	0.00155	CcSEcCtD
Metipranolol—Dyspnoea—Zonisamide—epilepsy syndrome	0.00111	0.00155	CcSEcCtD
Metipranolol—Somnolence—Zonisamide—epilepsy syndrome	0.00111	0.00155	CcSEcCtD
Metipranolol—Conjunctivitis—Gabapentin—epilepsy syndrome	0.00111	0.00154	CcSEcCtD
Metipranolol—Oedema—Lamotrigine—epilepsy syndrome	0.0011	0.00154	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.00109	0.00153	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.00109	0.00152	CcSEcCtD
Metipranolol—Nausea—Lacosamide—epilepsy syndrome	0.00109	0.00152	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.00108	0.00151	CcSEcCtD
Metipranolol—Visual impairment—Pregabalin—epilepsy syndrome	0.00107	0.0015	CcSEcCtD
Metipranolol—Epistaxis—Gabapentin—epilepsy syndrome	0.00107	0.0015	CcSEcCtD
Metipranolol—Dyspnoea—Clonazepam—epilepsy syndrome	0.00107	0.0015	CcSEcCtD
Metipranolol—Somnolence—Clonazepam—epilepsy syndrome	0.00107	0.00149	CcSEcCtD
Metipranolol—Dyspnoea—Phenytoin—epilepsy syndrome	0.00106	0.00149	CcSEcCtD
Metipranolol—Somnolence—Phenytoin—epilepsy syndrome	0.00106	0.00148	CcSEcCtD
Metipranolol—Hypersensitivity—Midazolam—epilepsy syndrome	0.00106	0.00148	CcSEcCtD
Metipranolol—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.00106	0.00148	CcSEcCtD
Metipranolol—Somnolence—Oxcarbazepine—epilepsy syndrome	0.00106	0.00147	CcSEcCtD
Metipranolol—Nausea—Clobazam—epilepsy syndrome	0.00105	0.00147	CcSEcCtD
Metipranolol—Asthenia—Propofol—epilepsy syndrome	0.00105	0.00147	CcSEcCtD
Metipranolol—Tension—Valproic Acid—epilepsy syndrome	0.00105	0.00147	CcSEcCtD
Metipranolol—Dizziness—Acetazolamide—epilepsy syndrome	0.00105	0.00146	CcSEcCtD
Metipranolol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00105	0.00146	CcSEcCtD
Metipranolol—Alprenolol—CYP2D6—epilepsy syndrome	0.00105	0.1	CrCbGaD
Metipranolol—Angina pectoris—Topiramate—epilepsy syndrome	0.00104	0.00146	CcSEcCtD
Metipranolol—Nervousness—Valproic Acid—epilepsy syndrome	0.00104	0.00145	CcSEcCtD
Metipranolol—Bradycardia—Gabapentin—epilepsy syndrome	0.00104	0.00145	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.00104	0.00145	CcSEcCtD
Metipranolol—Asthenia—Midazolam—epilepsy syndrome	0.00103	0.00144	CcSEcCtD
Metipranolol—Bronchitis—Topiramate—epilepsy syndrome	0.00103	0.00144	CcSEcCtD
Metipranolol—Rhinitis—Gabapentin—epilepsy syndrome	0.00102	0.00143	CcSEcCtD
Metipranolol—Asthenia—Levetiracetam—epilepsy syndrome	0.00102	0.00142	CcSEcCtD
Metipranolol—Dyspnoea—Carbamazepine—epilepsy syndrome	0.00102	0.00142	CcSEcCtD
Metipranolol—Somnolence—Carbamazepine—epilepsy syndrome	0.00101	0.00142	CcSEcCtD
Metipranolol—Vision blurred—Valproic Acid—epilepsy syndrome	0.00101	0.00141	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.001	0.0014	CcSEcCtD
Metipranolol—Headache—Acetazolamide—epilepsy syndrome	0.000992	0.00139	CcSEcCtD
Metipranolol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000985	0.00138	CcSEcCtD
Metipranolol—Asthenia—Fosphenytoin—epilepsy syndrome	0.000984	0.00137	CcSEcCtD
Metipranolol—Visual impairment—Gabapentin—epilepsy syndrome	0.000984	0.00137	CcSEcCtD
Metipranolol—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000981	0.00137	CcSEcCtD
Metipranolol—Somnolence—Lamotrigine—epilepsy syndrome	0.000979	0.00137	CcSEcCtD
Metipranolol—Dizziness—Propofol—epilepsy syndrome	0.000972	0.00136	CcSEcCtD
Metipranolol—Metoprolol—CYP2D6—epilepsy syndrome	0.000972	0.0932	CrCbGaD
Metipranolol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000969	0.00135	CcSEcCtD
Metipranolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000959	0.00134	CcSEcCtD
Metipranolol—Dizziness—Midazolam—epilepsy syndrome	0.000951	0.00133	CcSEcCtD
Metipranolol—Tension—Pregabalin—epilepsy syndrome	0.000951	0.00133	CcSEcCtD
Metipranolol—Palpitations—Valproic Acid—epilepsy syndrome	0.000947	0.00132	CcSEcCtD
Metipranolol—Asthenia—Diazepam—epilepsy syndrome	0.000944	0.00132	CcSEcCtD
Metipranolol—Nervousness—Pregabalin—epilepsy syndrome	0.000941	0.00132	CcSEcCtD
Metipranolol—Nausea—Acetazolamide—epilepsy syndrome	0.00094	0.00131	CcSEcCtD
Metipranolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000939	0.00131	CcSEcCtD
Metipranolol—Cough—Valproic Acid—epilepsy syndrome	0.000935	0.00131	CcSEcCtD
Metipranolol—Conjunctivitis—Topiramate—epilepsy syndrome	0.00093	0.0013	CcSEcCtD
Metipranolol—Rash—Propofol—epilepsy syndrome	0.000927	0.0013	CcSEcCtD
Metipranolol—Dermatitis—Propofol—epilepsy syndrome	0.000926	0.00129	CcSEcCtD
Metipranolol—Hypertension—Valproic Acid—epilepsy syndrome	0.000925	0.00129	CcSEcCtD
Metipranolol—Headache—Propofol—epilepsy syndrome	0.000921	0.00129	CcSEcCtD
Metipranolol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000918	0.00128	CcSEcCtD
Metipranolol—Asthenia—Felbamate—epilepsy syndrome	0.000914	0.00128	CcSEcCtD
Metipranolol—Vision blurred—Pregabalin—epilepsy syndrome	0.000913	0.00128	CcSEcCtD
Metipranolol—Myalgia—Valproic Acid—epilepsy syndrome	0.000912	0.00128	CcSEcCtD
Metipranolol—Anxiety—Valproic Acid—epilepsy syndrome	0.000909	0.00127	CcSEcCtD
Metipranolol—Rash—Midazolam—epilepsy syndrome	0.000907	0.00127	CcSEcCtD
Metipranolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000907	0.00127	CcSEcCtD
Metipranolol—Dermatitis—Midazolam—epilepsy syndrome	0.000906	0.00127	CcSEcCtD
Metipranolol—Epistaxis—Topiramate—epilepsy syndrome	0.000902	0.00126	CcSEcCtD
Metipranolol—Discomfort—Valproic Acid—epilepsy syndrome	0.000901	0.00126	CcSEcCtD
Metipranolol—Headache—Midazolam—epilepsy syndrome	0.000901	0.00126	CcSEcCtD
Metipranolol—Pindolol—CYP2D6—epilepsy syndrome	0.000899	0.0862	CrCbGaD
Metipranolol—Rash—Levetiracetam—epilepsy syndrome	0.000896	0.00125	CcSEcCtD
Metipranolol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000895	0.00125	CcSEcCtD
Metipranolol—Asthenia—Zonisamide—epilepsy syndrome	0.000894	0.00125	CcSEcCtD
Metipranolol—Atenolol—ABCB1—epilepsy syndrome	0.000891	0.0854	CrCbGaD
Metipranolol—Headache—Levetiracetam—epilepsy syndrome	0.00089	0.00124	CcSEcCtD
Metipranolol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000885	0.00124	CcSEcCtD
Metipranolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000884	0.00123	CcSEcCtD
Metipranolol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000879	0.00123	CcSEcCtD
Metipranolol—Oedema—Valproic Acid—epilepsy syndrome	0.000875	0.00122	CcSEcCtD
Metipranolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000874	0.00122	CcSEcCtD
Metipranolol—Bradycardia—Topiramate—epilepsy syndrome	0.000874	0.00122	CcSEcCtD
Metipranolol—Nausea—Propofol—epilepsy syndrome	0.000873	0.00122	CcSEcCtD
Metipranolol—Tension—Gabapentin—epilepsy syndrome	0.000872	0.00122	CcSEcCtD
Metipranolol—Dizziness—Diazepam—epilepsy syndrome	0.00087	0.00122	CcSEcCtD
Metipranolol—Rash—Fosphenytoin—epilepsy syndrome	0.000864	0.00121	CcSEcCtD
Metipranolol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000864	0.00121	CcSEcCtD
Metipranolol—Nervousness—Gabapentin—epilepsy syndrome	0.000863	0.00121	CcSEcCtD
Metipranolol—Asthenia—Clonazepam—epilepsy syndrome	0.000862	0.0012	CcSEcCtD
Metipranolol—Rhinitis—Topiramate—epilepsy syndrome	0.000861	0.0012	CcSEcCtD
Metipranolol—Headache—Fosphenytoin—epilepsy syndrome	0.000859	0.0012	CcSEcCtD
Metipranolol—Palpitations—Pregabalin—epilepsy syndrome	0.000856	0.0012	CcSEcCtD
Metipranolol—Asthenia—Phenytoin—epilepsy syndrome	0.000856	0.0012	CcSEcCtD
Metipranolol—Nausea—Midazolam—epilepsy syndrome	0.000854	0.00119	CcSEcCtD
Metipranolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000852	0.00119	CcSEcCtD
Metipranolol—Cough—Pregabalin—epilepsy syndrome	0.000845	0.00118	CcSEcCtD
Metipranolol—Nausea—Levetiracetam—epilepsy syndrome	0.000844	0.00118	CcSEcCtD
Metipranolol—Rash—Vigabatrin—epilepsy syndrome	0.000843	0.00118	CcSEcCtD
Metipranolol—Dizziness—Felbamate—epilepsy syndrome	0.000842	0.00118	CcSEcCtD
Metipranolol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000842	0.00118	CcSEcCtD
Metipranolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000839	0.00117	CcSEcCtD
Metipranolol—Vision blurred—Gabapentin—epilepsy syndrome	0.000837	0.00117	CcSEcCtD
Metipranolol—Headache—Vigabatrin—epilepsy syndrome	0.000837	0.00117	CcSEcCtD
Metipranolol—Hypertension—Pregabalin—epilepsy syndrome	0.000837	0.00117	CcSEcCtD
Metipranolol—Rash—Diazepam—epilepsy syndrome	0.000829	0.00116	CcSEcCtD
Metipranolol—Dermatitis—Diazepam—epilepsy syndrome	0.000829	0.00116	CcSEcCtD
Metipranolol—Visual impairment—Topiramate—epilepsy syndrome	0.000827	0.00116	CcSEcCtD
Metipranolol—Myalgia—Pregabalin—epilepsy syndrome	0.000825	0.00115	CcSEcCtD
Metipranolol—Dizziness—Zonisamide—epilepsy syndrome	0.000824	0.00115	CcSEcCtD
Metipranolol—Headache—Diazepam—epilepsy syndrome	0.000824	0.00115	CcSEcCtD
Metipranolol—Anxiety—Pregabalin—epilepsy syndrome	0.000822	0.00115	CcSEcCtD
Metipranolol—Acebutolol—ABCB1—epilepsy syndrome	0.000822	0.0788	CrCbGaD
Metipranolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000817	0.00114	CcSEcCtD
Metipranolol—Discomfort—Pregabalin—epilepsy syndrome	0.000815	0.00114	CcSEcCtD
Metipranolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000814	0.00114	CcSEcCtD
Metipranolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000811	0.00113	CcSEcCtD
Metipranolol—Rash—Felbamate—epilepsy syndrome	0.000803	0.00112	CcSEcCtD
Metipranolol—Dermatitis—Felbamate—epilepsy syndrome	0.000802	0.00112	CcSEcCtD
Metipranolol—Headache—Felbamate—epilepsy syndrome	0.000798	0.00111	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000797	0.00111	CcSEcCtD
Metipranolol—Dizziness—Clonazepam—epilepsy syndrome	0.000794	0.00111	CcSEcCtD
Metipranolol—Nausea—Vigabatrin—epilepsy syndrome	0.000794	0.00111	CcSEcCtD
Metipranolol—Oedema—Pregabalin—epilepsy syndrome	0.000791	0.00111	CcSEcCtD
Metipranolol—Asthenia—Lamotrigine—epilepsy syndrome	0.00079	0.0011	CcSEcCtD
Metipranolol—Dizziness—Phenytoin—epilepsy syndrome	0.000789	0.0011	CcSEcCtD
Metipranolol—Rash—Zonisamide—epilepsy syndrome	0.000786	0.0011	CcSEcCtD
Metipranolol—Palpitations—Gabapentin—epilepsy syndrome	0.000785	0.0011	CcSEcCtD
Metipranolol—Dermatitis—Zonisamide—epilepsy syndrome	0.000785	0.0011	CcSEcCtD
Metipranolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000785	0.0011	CcSEcCtD
Metipranolol—Nausea—Diazepam—epilepsy syndrome	0.000781	0.00109	CcSEcCtD
Metipranolol—Headache—Zonisamide—epilepsy syndrome	0.000781	0.00109	CcSEcCtD
Metipranolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00078	0.00109	CcSEcCtD
Metipranolol—Somnolence—Valproic Acid—epilepsy syndrome	0.000778	0.00109	CcSEcCtD
Metipranolol—Cough—Gabapentin—epilepsy syndrome	0.000775	0.00108	CcSEcCtD
Metipranolol—Hypertension—Gabapentin—epilepsy syndrome	0.000767	0.00107	CcSEcCtD
Metipranolol—Rash—Clonazepam—epilepsy syndrome	0.000757	0.00106	CcSEcCtD
Metipranolol—Dermatitis—Clonazepam—epilepsy syndrome	0.000757	0.00106	CcSEcCtD
Metipranolol—Myalgia—Gabapentin—epilepsy syndrome	0.000756	0.00106	CcSEcCtD
Metipranolol—Nausea—Felbamate—epilepsy syndrome	0.000756	0.00106	CcSEcCtD
Metipranolol—Anxiety—Gabapentin—epilepsy syndrome	0.000754	0.00105	CcSEcCtD
Metipranolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000753	0.00105	CcSEcCtD
Metipranolol—Headache—Clonazepam—epilepsy syndrome	0.000753	0.00105	CcSEcCtD
Metipranolol—Rash—Phenytoin—epilepsy syndrome	0.000752	0.00105	CcSEcCtD
Metipranolol—Dermatitis—Phenytoin—epilepsy syndrome	0.000752	0.00105	CcSEcCtD
Metipranolol—Rash—Oxcarbazepine—epilepsy syndrome	0.000748	0.00105	CcSEcCtD
Metipranolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000748	0.00104	CcSEcCtD
Metipranolol—Headache—Phenytoin—epilepsy syndrome	0.000747	0.00104	CcSEcCtD
Metipranolol—Discomfort—Gabapentin—epilepsy syndrome	0.000747	0.00104	CcSEcCtD
Metipranolol—Headache—Oxcarbazepine—epilepsy syndrome	0.000744	0.00104	CcSEcCtD
Metipranolol—Nausea—Zonisamide—epilepsy syndrome	0.00074	0.00103	CcSEcCtD
Metipranolol—Tension—Topiramate—epilepsy syndrome	0.000733	0.00103	CcSEcCtD
Metipranolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000728	0.00102	CcSEcCtD
Metipranolol—Nervousness—Topiramate—epilepsy syndrome	0.000726	0.00101	CcSEcCtD
Metipranolol—Oedema—Gabapentin—epilepsy syndrome	0.000725	0.00101	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00072	0.00101	CcSEcCtD
Metipranolol—Rash—Carbamazepine—epilepsy syndrome	0.000718	0.001	CcSEcCtD
Metipranolol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000717	0.001	CcSEcCtD
Metipranolol—Nausea—Clonazepam—epilepsy syndrome	0.000713	0.000997	CcSEcCtD
Metipranolol—Headache—Carbamazepine—epilepsy syndrome	0.000713	0.000997	CcSEcCtD
Metipranolol—Nausea—Phenytoin—epilepsy syndrome	0.000709	0.00099	CcSEcCtD
Metipranolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000705	0.000985	CcSEcCtD
Metipranolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000705	0.000985	CcSEcCtD
Metipranolol—Vision blurred—Topiramate—epilepsy syndrome	0.000704	0.000984	CcSEcCtD
Metipranolol—Somnolence—Pregabalin—epilepsy syndrome	0.000703	0.000982	CcSEcCtD
Metipranolol—Rash—Lamotrigine—epilepsy syndrome	0.000694	0.00097	CcSEcCtD
Metipranolol—Metoprolol—ABCB1—epilepsy syndrome	0.000694	0.0665	CrCbGaD
Metipranolol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000693	0.000969	CcSEcCtD
Metipranolol—Headache—Lamotrigine—epilepsy syndrome	0.00069	0.000964	CcSEcCtD
Metipranolol—Nausea—Carbamazepine—epilepsy syndrome	0.000676	0.000945	CcSEcCtD
Metipranolol—Propranolol—CYP2C19—epilepsy syndrome	0.000662	0.0634	CrCbGaD
Metipranolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000661	0.000923	CcSEcCtD
Metipranolol—Palpitations—Topiramate—epilepsy syndrome	0.000661	0.000923	CcSEcCtD
Metipranolol—Nausea—Lamotrigine—epilepsy syndrome	0.000654	0.000914	CcSEcCtD
Metipranolol—Cough—Topiramate—epilepsy syndrome	0.000652	0.000912	CcSEcCtD
Metipranolol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000646	0.000903	CcSEcCtD
Metipranolol—Hypertension—Topiramate—epilepsy syndrome	0.000645	0.000902	CcSEcCtD
Metipranolol—Somnolence—Gabapentin—epilepsy syndrome	0.000645	0.000901	CcSEcCtD
Metipranolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000644	0.000901	CcSEcCtD
Metipranolol—Myalgia—Topiramate—epilepsy syndrome	0.000636	0.000889	CcSEcCtD
Metipranolol—Anxiety—Topiramate—epilepsy syndrome	0.000634	0.000886	CcSEcCtD
Metipranolol—Discomfort—Topiramate—epilepsy syndrome	0.000629	0.000879	CcSEcCtD
Metipranolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000628	0.000877	CcSEcCtD
Metipranolol—Oedema—Topiramate—epilepsy syndrome	0.00061	0.000853	CcSEcCtD
Metipranolol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000583	0.000814	CcSEcCtD
Metipranolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000578	0.000808	CcSEcCtD
Metipranolol—Asthenia—Pregabalin—epilepsy syndrome	0.000567	0.000793	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000556	0.000777	CcSEcCtD
Metipranolol—Rash—Valproic Acid—epilepsy syndrome	0.000551	0.000771	CcSEcCtD
Metipranolol—Dermatitis—Valproic Acid—epilepsy syndrome	0.000551	0.00077	CcSEcCtD
Metipranolol—Headache—Valproic Acid—epilepsy syndrome	0.000548	0.000766	CcSEcCtD
Metipranolol—Dyspnoea—Topiramate—epilepsy syndrome	0.000544	0.00076	CcSEcCtD
Metipranolol—Somnolence—Topiramate—epilepsy syndrome	0.000542	0.000758	CcSEcCtD
Metipranolol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000534	0.000747	CcSEcCtD
Metipranolol—Dizziness—Pregabalin—epilepsy syndrome	0.000523	0.000731	CcSEcCtD
Metipranolol—Asthenia—Gabapentin—epilepsy syndrome	0.00052	0.000727	CcSEcCtD
Metipranolol—Nausea—Valproic Acid—epilepsy syndrome	0.00052	0.000726	CcSEcCtD
Metipranolol—Rash—Pregabalin—epilepsy syndrome	0.000499	0.000697	CcSEcCtD
Metipranolol—Dermatitis—Pregabalin—epilepsy syndrome	0.000498	0.000696	CcSEcCtD
Metipranolol—Headache—Pregabalin—epilepsy syndrome	0.000495	0.000692	CcSEcCtD
Metipranolol—Propranolol—CYP2D6—epilepsy syndrome	0.000491	0.047	CrCbGaD
Metipranolol—Dizziness—Gabapentin—epilepsy syndrome	0.000479	0.00067	CcSEcCtD
Metipranolol—Nausea—Pregabalin—epilepsy syndrome	0.00047	0.000656	CcSEcCtD
Metipranolol—Rash—Gabapentin—epilepsy syndrome	0.000457	0.000639	CcSEcCtD
Metipranolol—Dermatitis—Gabapentin—epilepsy syndrome	0.000457	0.000638	CcSEcCtD
Metipranolol—Headache—Gabapentin—epilepsy syndrome	0.000454	0.000635	CcSEcCtD
Metipranolol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000449	0.000628	CcSEcCtD
Metipranolol—Asthenia—Topiramate—epilepsy syndrome	0.000438	0.000612	CcSEcCtD
Metipranolol—Nausea—Gabapentin—epilepsy syndrome	0.000431	0.000602	CcSEcCtD
Metipranolol—Dizziness—Topiramate—epilepsy syndrome	0.000403	0.000564	CcSEcCtD
Metipranolol—Rash—Topiramate—epilepsy syndrome	0.000385	0.000538	CcSEcCtD
Metipranolol—Dermatitis—Topiramate—epilepsy syndrome	0.000384	0.000537	CcSEcCtD
Metipranolol—Headache—Topiramate—epilepsy syndrome	0.000382	0.000534	CcSEcCtD
Metipranolol—Nausea—Topiramate—epilepsy syndrome	0.000362	0.000506	CcSEcCtD
Metipranolol—Propranolol—ABCB1—epilepsy syndrome	0.00035	0.0336	CrCbGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000141	0.000513	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00014	0.000513	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SSTR3—epilepsy syndrome	0.00014	0.000512	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—OXT—epilepsy syndrome	0.000138	0.000504	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL3—epilepsy syndrome	0.000138	0.000504	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CRH—epilepsy syndrome	0.000138	0.000504	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000138	0.000504	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR9—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR8—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—SST—epilepsy syndrome	0.000138	0.000502	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000137	0.000501	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM4—epilepsy syndrome	0.000135	0.000493	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM3—epilepsy syndrome	0.000135	0.000493	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR9—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPY2R—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SSTR1—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR8—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000135	0.000491	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DUSP4—epilepsy syndrome	0.000132	0.000483	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SSTR2—epilepsy syndrome	0.000132	0.000483	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000132	0.000482	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000132	0.000482	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM4—epilepsy syndrome	0.000132	0.000482	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM3—epilepsy syndrome	0.000132	0.000482	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.00013	0.000473	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DUSP4—epilepsy syndrome	0.00013	0.000473	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SSTR2—epilepsy syndrome	0.00013	0.000473	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000129	0.000472	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000129	0.000472	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000129	0.000472	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM8—epilepsy syndrome	0.000128	0.000467	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PGF—epilepsy syndrome	0.000128	0.000467	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000128	0.000466	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—SST—epilepsy syndrome	0.000128	0.000466	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000127	0.000463	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000127	0.000462	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000126	0.000461	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—POMC—epilepsy syndrome	0.000125	0.000457	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM8—epilepsy syndrome	0.000125	0.000457	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PGF—epilepsy syndrome	0.000125	0.000457	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000125	0.000456	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCR2—epilepsy syndrome	0.000125	0.000456	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—SST—epilepsy syndrome	0.000125	0.000456	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000124	0.000452	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000123	0.000447	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—POMC—epilepsy syndrome	0.000123	0.000447	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000122	0.000446	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000122	0.000445	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000122	0.000445	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000121	0.00044	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.00012	0.000438	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.00012	0.000438	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CCL2—epilepsy syndrome	0.00012	0.000438	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OPRD1—epilepsy syndrome	0.000119	0.000436	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GNAO1—epilepsy syndrome	0.000119	0.000436	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000118	0.000431	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000118	0.00043	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000117	0.000428	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000117	0.000428	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000117	0.000428	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000117	0.000427	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	0.000117	0.000427	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	0.000117	0.000427	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	0.000117	0.000427	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	0.000115	0.000421	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000115	0.000419	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000115	0.000419	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	0.000114	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	0.000114	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	0.000114	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	0.000114	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	0.000112	0.00041	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000112	0.000407	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.00011	0.000402	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	0.00011	0.000402	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	0.00011	0.000402	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	0.00011	0.0004	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000109	0.000398	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	0.000109	0.000397	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	0.000109	0.000397	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000109	0.000397	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000108	0.000393	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	0.000108	0.000393	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	0.000108	0.000393	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	0.000107	0.000391	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	0.000107	0.000389	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	0.000106	0.000388	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	0.000106	0.000388	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	0.000106	0.000388	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000104	0.000381	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	0.000104	0.00038	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	0.000102	0.000373	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000102	0.000373	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000102	0.000373	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000102	0.000372	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	0.0001	0.000365	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	0.0001	0.000365	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	0.0001	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	9.99e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	9.95e-05	0.000363	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	9.78e-05	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	9.73e-05	0.000355	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	9.67e-05	0.000353	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	9.54e-05	0.000348	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	9.46e-05	0.000345	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	9.39e-05	0.000343	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	9.33e-05	0.000341	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	9.19e-05	0.000335	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	9.06e-05	0.000331	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	8.87e-05	0.000324	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.86e-05	0.000323	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	8.86e-05	0.000323	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	8.68e-05	0.000317	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.67e-05	0.000316	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	8.64e-05	0.000315	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.64e-05	0.000315	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	8.45e-05	0.000309	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	8.45e-05	0.000309	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	8.41e-05	0.000307	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	8.34e-05	0.000304	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	8.34e-05	0.000304	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	8.34e-05	0.000304	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	8.34e-05	0.000304	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	8.34e-05	0.000304	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	8.23e-05	0.0003	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	8.23e-05	0.0003	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	8.16e-05	0.000298	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	8.16e-05	0.000298	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	8.16e-05	0.000298	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	8.16e-05	0.000298	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	8.16e-05	0.000298	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.05e-05	0.000294	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	8.05e-05	0.000294	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	7.87e-05	0.000287	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.77e-05	0.000284	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	7.75e-05	0.000283	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	7.75e-05	0.000283	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	7.64e-05	0.000279	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.6e-05	0.000277	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	7.58e-05	0.000277	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	7.58e-05	0.000277	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	7.54e-05	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	7.54e-05	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	7.54e-05	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	7.48e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	7.47e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.38e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	7.38e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	7.38e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	7.38e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	7.35e-05	0.000268	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	7.31e-05	0.000267	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.22e-05	0.000263	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	7.19e-05	0.000262	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.09e-05	0.000259	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	7.09e-05	0.000259	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	7.08e-05	0.000258	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.06e-05	0.000258	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.03e-05	0.000257	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	6.96e-05	0.000254	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	6.96e-05	0.000254	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	6.94e-05	0.000253	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	6.94e-05	0.000253	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	6.93e-05	0.000253	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	6.93e-05	0.000253	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	6.9e-05	0.000252	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	6.88e-05	0.000251	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	6.81e-05	0.000248	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	6.81e-05	0.000248	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	6.79e-05	0.000248	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	6.78e-05	0.000248	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	6.64e-05	0.000242	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	6.59e-05	0.000241	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	6.47e-05	0.000236	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	6.45e-05	0.000235	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	6.43e-05	0.000235	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	6.33e-05	0.000231	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	6.32e-05	0.000231	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	6.29e-05	0.00023	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	6.29e-05	0.00023	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	6.18e-05	0.000226	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	6.15e-05	0.000225	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	5.98e-05	0.000218	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	5.92e-05	0.000216	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	5.9e-05	0.000215	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	5.85e-05	0.000213	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	5.79e-05	0.000211	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	5.77e-05	0.000211	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	5.72e-05	0.000209	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	5.59e-05	0.000204	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	5.4e-05	0.000197	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	5.29e-05	0.000193	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	5.26e-05	0.000192	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	5.24e-05	0.000191	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	5.23e-05	0.000191	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	5.14e-05	0.000188	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	5.12e-05	0.000187	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	5.11e-05	0.000187	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.05e-05	0.000184	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	5e-05	0.000182	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.94e-05	0.00018	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	4.89e-05	0.000178	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	4.86e-05	0.000177	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	4.76e-05	0.000174	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	4.75e-05	0.000173	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	4.65e-05	0.00017	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	4.52e-05	0.000165	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	4.51e-05	0.000165	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	4.42e-05	0.000161	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	4.42e-05	0.000161	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	4.41e-05	0.000161	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	4.33e-05	0.000158	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	4.32e-05	0.000158	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	4.24e-05	0.000155	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	4.17e-05	0.000152	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	4.15e-05	0.000152	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	4.08e-05	0.000149	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	4.06e-05	0.000148	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	3.8e-05	0.000139	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	3.72e-05	0.000136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	3.72e-05	0.000136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	3.64e-05	0.000133	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	3.36e-05	0.000123	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	3.29e-05	0.00012	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	3.12e-05	0.000114	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	3.06e-05	0.000112	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	3.05e-05	0.000111	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	2.99e-05	0.000109	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.84e-05	0.000104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	2.81e-05	0.000103	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.78e-05	0.000101	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	2.75e-05	0.0001	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	2.73e-05	9.97e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	2.67e-05	9.75e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	2.66e-05	9.7e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	2.6e-05	9.49e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.58e-05	9.41e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	2.52e-05	9.2e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.45e-05	8.94e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	2.4e-05	8.75e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.39e-05	8.71e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.33e-05	8.52e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.52e-05	5.56e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.49e-05	5.43e-05	CbGpPWpGaD
